Patents Assigned to REVEN PHARMACEUTICALS, INC.
  • Publication number: 20220096538
    Abstract: The disclosure relates to pharmaceutical compositions and methods for the prevention and/or treatment of inflammation, disease, and disorders. The treatment may include treatment of COVID-19.
    Type: Application
    Filed: September 30, 2021
    Publication date: March 31, 2022
    Applicant: Reven Pharmaceuticals Inc.
    Inventors: Fatih M. Uckun, Michael A. Volk, Peter Lange, Brian D. Denomme, Hendrick Johanness Petrus Van Wyk
  • Publication number: 20220079978
    Abstract: The present invention is directed to methods for treating or ameliorating skin conditions, diabetic conditions, cardiovascular conditions, cancer, infections or metal poisoning, enhancing performance, or providing nutritional support, comprising administering to a subject in need thereof compositions comprising a magnetic dipole stabilized solution (MDSS). The MDSS solution may include additional components and can be provided in a kit.
    Type: Application
    Filed: November 24, 2021
    Publication date: March 17, 2022
    Applicant: REVEN PHARMACEUTICALS, INC.
    Inventors: Peter Lange, Brian Denomme, Henk Van Wyk, Mariette Van Wyk, Tracy L. Krebs, Sezgin Ozgur, Zishan Haroon
  • Patent number: 11202798
    Abstract: The present invention is directed to methods for treating or ameliorating skin conditions, diabetic conditions, cardiovascular conditions, cancer, infections or metal poisoning, enhancing performance, or providing nutritional support, comprising administering to a subject in need thereof compositions comprising a magnetic dipole stabilized solution (MDSS). The MDSS solution may include additional components and can be provided in a kit.
    Type: Grant
    Filed: December 20, 2017
    Date of Patent: December 21, 2021
    Assignee: REVEN PHARMACEUTICALS, INC.
    Inventors: Peter Lange, Brian Denomme, Henk Van Wyk, Mariette Van Wyk, Tracy L. Krebs, Sezgin Ozgur, Zishan Haroon
  • Publication number: 20210361562
    Abstract: Compositions comprising electro-activated aqueous solutions and methods for the prevention and treatment of dysfunctional cardiovascular conditions are provided.
    Type: Application
    Filed: August 6, 2021
    Publication date: November 25, 2021
    Applicant: Reven Pharmaceuticals Inc.
    Inventors: Henk Van Wyk, Mariette Van Wyk, Trace Krebs, Peter Lange, Brian Denomme, Michael A. Volk
  • Patent number: 11110053
    Abstract: Compositions comprising electro-activated aqueous solutions and methods for the prevention and treatment of dysfunctional cardiovascular conditions are provided.
    Type: Grant
    Filed: August 31, 2017
    Date of Patent: September 7, 2021
    Assignee: REVEN PHARMACEUTICALS INC.
    Inventors: Henk Van Wyk, Mariette Van Wyk, Trace Krebs, Peter Lange, Brian Denomme, Michael A. Volk
  • Patent number: 10849848
    Abstract: Compositions comprising electro-activated aqueous solutions and methods for the prevention and treatment of dysfunctional cardiovascular conditions are provided.
    Type: Grant
    Filed: August 31, 2017
    Date of Patent: December 1, 2020
    Assignee: REVEN PHARMACEUTICALS INC.
    Inventors: Henk Van Wyk, Mariette Van Wyk, Trace Krebs, Peter Lange, Brian Denomme, Michael A. Volk
  • Publication number: 20180243332
    Abstract: The present invention is directed to methods for treating or ameliorating skin conditions, diabetic conditions, cardiovascular conditions, cancer, infections or metal poisoning, enhancing performance, or providing nutritional support, comprising administering to a subject in need thereof compositions comprising a magnetic dipole stabilized solution (MDSS). The MDSS solution may include additional components and can be provided in a kit.
    Type: Application
    Filed: December 20, 2017
    Publication date: August 30, 2018
    Applicant: REVEN PHARMACEUTICALS, INC.
    Inventors: Peter Lange, Brian Denomme, Henk Van Wyk, Mariette Van Wyk, Tracy L. Krebs, Sezgin Ozgur, Zishan Haroon
  • Patent number: 9867849
    Abstract: The present invention is directed to methods for treating or ameliorating skin conditions, diabetic conditions, cardiovascular conditions, cancer, infections or metal poisoning, enhancing performance, or providing nutritional support, comprising administering to a subject in need thereof compositions comprising a magnetic dipole stabilized solution (MDSS). The MDSS solution may include additional components and can be provided in a kit.
    Type: Grant
    Filed: January 4, 2017
    Date of Patent: January 16, 2018
    Assignee: REVEN PHARMACEUTICALS, INC.
    Inventors: Peter Lange, Brian Denomme, Henk Van Wyk, Mariette Van Wyk, Tracy L. Krebs, Sezgin Ozgur, Zishan Haroon
  • Publication number: 20170360696
    Abstract: Compositions comprising electro-activated aqueous solutions and methods for the prevention and treatment of dysfunctional cardiovascular conditions are provided.
    Type: Application
    Filed: August 31, 2017
    Publication date: December 21, 2017
    Applicant: REVEN PHARMACEUTICALS INC.
    Inventors: Henk Van Wyk, Mariette Van Wyk, Trace Krebs, Peter Lange, Brian Denomme, Michael A. Volk
  • Patent number: 9775798
    Abstract: Compositions comprising electro-activated aqueous solutions and methods for the prevention and treatment of dysfunctional cardiovascular conditions are provided.
    Type: Grant
    Filed: November 21, 2014
    Date of Patent: October 3, 2017
    Assignee: REVEN PHARMACEUTICALS, INC.
    Inventors: Henk Van Wyk, Mariette Van Wyk, Trace Krebs, Peter Lange, Brian Denomme, Michael A. Volk
  • Publication number: 20170112872
    Abstract: The present invention is directed to methods for treating or ameliorating skin conditions, diabetic conditions, cardiovascular conditions, cancer, infections or metal poisoning, enhancing performance, or providing nutritional support, comprising administering to a subject in need thereof compositions comprising a magnetic dipole stabilized solution (MDSS). The MDSS solution may include additional components and can be provided in a kit.
    Type: Application
    Filed: January 4, 2017
    Publication date: April 27, 2017
    Applicant: REVEN PHARMACEUTICALS, INC.
    Inventors: Peter Lange, Brian Denomme, Henk Van Wyk, Mariette Van Wyk, Tracy L. Krebs, Sezgin Ozgur, Zishan Haroon
  • Patent number: 9572810
    Abstract: The present invention is directed to methods for treating or ameliorating skin conditions, diabetic conditions, cardiovascular conditions, cancer, infections or metal poisoning, enhancing performance, or providing nutritional support, comprising administering to a subject in need thereof compositions comprising a magnetic dipole stabilized solution (MDSS). The MDSS solution may include additional components and can be provided in a kit.
    Type: Grant
    Filed: September 4, 2013
    Date of Patent: February 21, 2017
    Assignee: REVEN PHARMACEUTICALS, INC.
    Inventors: Peter Lange, Brian Denomme, Henk Van Wyk, Mariette Van Wyk, Tracy L. Krebs, Sezgin Ozgur, Zishan Haroon
  • Patent number: 9101537
    Abstract: Compositions comprising electro-activated aqueous solutions and methods for the prevention and treatment of dysfunctional cardiovascular conditions are provided.
    Type: Grant
    Filed: July 24, 2009
    Date of Patent: August 11, 2015
    Assignee: REVEN PHARMACEUTICALS, INC.
    Inventors: Henk Van Wyk, Mariette Van Wyk, Trace Krebs, Peter Lange, Brian Denomme, Michael A. Volk
  • Patent number: 9089511
    Abstract: Compositions comprising electro-activated aqueous solutions and methods for the prevention and treatment of dysfunctional cardiovascular conditions are provided.
    Type: Grant
    Filed: November 21, 2014
    Date of Patent: July 28, 2015
    Assignee: REVEN PHARMACEUTICALS, INC.
    Inventors: Henk Van Wyk, Mariette Van Wyk, Trace Krebs, Peter Lange, Brian Denomme, Michael A. Volk
  • Patent number: 9089602
    Abstract: Compositions comprising electro-activated aqueous solutions and methods for the prevention and treatment of dysfunctional cardiovascular conditions are provided.
    Type: Grant
    Filed: November 21, 2014
    Date of Patent: July 28, 2015
    Assignee: REVEN PHARMACEUTICALS, INC.
    Inventors: Henk Van Wyk, Mariette Van Wyk, Trace Krebs, Peter Lange, Brian Denomme, Michael A. Volk
  • Publication number: 20140004093
    Abstract: The present invention is directed to methods for treating or ameliorating skin conditions, diabetic conditions, cardiovascular conditions, cancer, infections or metal poisoning, enhancing performance, or providing nutritional support, comprising administering to a subject in need thereof compositions comprising a magnetic dipole stabilized solution (MDSS). The MDSS solution may include additional components and can be provided in a kit.
    Type: Application
    Filed: September 4, 2013
    Publication date: January 2, 2014
    Applicant: REVEN PHARMACEUTICALS, INC.
    Inventors: Peter LANGE, Brian DENOMME, Henk VAN WYK, Mariette VAN WYK, Tracy L. KREBS